Literature DB >> 30907382

Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.

Asher Mullard.   

Abstract

This corrects the article DOI: 10.1038/nrd.2016.158.

Entities:  

Year:  2016        PMID: 30907382     DOI: 10.1038/nrd.2016.172

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  1 in total

1.  Remyelination researchers regroup after proof-of-concept setback in multiple sclerosis.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2016-07-29       Impact factor: 84.694

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.